1. 2022
  2. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

    Haggenburg, S., Lissenberg-Witte, B. I., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., de Rooij, D. M., van Meerloo, J., Cloos, J., Kootstra, N. A., Wouters, D., Weijers, S. S., van Leeuwen, E. M. M., Bontkes, H. J., Tonouh-Aajoud, S., Heemskerk, M. H. M., Sanders, R. W., Roelandse-Koop, E., Hofsink, Q., Groen, K., & 28 othersÇetinel, L., Schellekens, L., den Hartog, Y. M., Toussaint, B., Kant, I. M. J., Graas, T., de Pater, E., Dik, W. A., Engel, M. D., Pierie, C. R. N., Janssen, S. R., van Dijkman, E., Poniman, M., Burger, J. A., Bouhuijs, J. H., Smits, G., Rots, N. Y., Zweegman, S., Kater, A. P., van Meerten, T., Mutsaers, P. G. N. J., van Doesum, J. A., Broers, A. E. C., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 8 Mar 2022, In: Blood advances. 6, 5, p. 1537-1546 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. A review of severe thrombocytopenia in Zika patients – Pathophysiology, treatment and outcome

    de Pijper, C. A., Schnyder, J. L., Stijnis, C., Goorhuis, A. & Grobusch, M. P., 1 Jan 2022, In: Travel medicine and infectious disease. 45, 102231.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial

    Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., te Boekhorst, P. A., Swaneveld, F., Novotny, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J., Heijmans, J. & Heijmans, J., 2022.

    Research output: Working paperPreprint

  5. 2021
  6. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

    The Guideline Committee of the European Study Group on Clostridioides difficile, 1 Dec 2021, In: Clinical microbiology and infection. 27, p. S1-S21

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

    Sablerolles, R. S. G., Goorhuis, A., GeurtsvanKessel, C. H., de Vries, R. D., Huckriede, A. L. W., Koopmans, M. P. G., Lafeber, M., Postma, D. F., van Baarle, D., Visser, L. G., Dalm, V. A. S. H., Kootstra, N. A., Rietdijk, W. J. R. & van der Kuy, P. H. M., 24 Sep 2021, In: Frontiers in immunology. 12, 753319.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Correspondence delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccine

    Grobusch, M. P., Schnyder, J., Garcia-Garrido, H. M., Wisman, J. J., Stijnis, C., Goorhuis, A., Hänscheid, T. & de Jong, H. K., 1 Sep 2021, In: Travel medicine and infectious disease. 43, 102093.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  9. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    HGID Lab, Bastard, P., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Manry, J., Michailidis, E., Hoffmann, H-H., Eto, S., Garcia-Prat, M., Bizien, L., Parra-Martínez, A., Yang, R., Haljasmägi, L., Migaud, M., Särekannu, K., Maslovskaja, J., de Prost, N., Tandjaoui-Lambiotte, Y., & 48 othersLuyt, C-E., Amador-Borrero, B., Gaudet, A., Poissy, J., Morel, P., Richard, P., Cognasse, F., Troya, J., Trouillet-Assant, S., Belot, A., Saker, K., Garçon, P., Rivière, J. G., Lagier, J-C., Gentile, S., Rosen, L. B., Shaw, E., Morio, T., Tanaka, J., Dalmau, D., Tharaux, P-L., Sene, D., Stepanian, A., Megarbane, B., Triantafyllia, V., Fekkar, A., Heath, J. R., Franco, J. L., Anaya, J-M., Study group members AMC, Koning, R., Wiersinga, W. J., de Bree, G. J., Geerlings, S. E., Goorhuis, B., Grobusch, M. P., Harris, V. C., Hermans, S. M., Hovius, J. W. R., Nellen, J., van der Poll, T., Prins, J. M., Stijnis, C. S., van der Valk, M., van Vugt, M., Hollmann, M. W., Preckel, P. D. . B. & Veelo, D. P., 19 Aug 2021, In: Science immunology. 6, 62, 26 p., eabl4340 .

    Research output: Contribution to journalArticleAcademicpeer-review

  10. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

    COVID Human Genetic Effort, Asano, T., Boisson, B., Onodi, F., Matuozzo, D., Moncada-Velez, M., Maglorius Renkilaraj, M. R. L., Zhang, P., Meertens, L., Bolze, A., Materna, M., Korniotis, S., Gervais, A., Talouarn, E., Bigio, B., Seeleuthner, Y., Bilguvar, K., Zhang, Y., Neehus, A-L., Ogishi, M., & 50 othersPelham, S. J., Le Voyer, T., Rosain, J., Philippot, Q., Soler-Palacín, P., Colobran, R., Martin-Nalda, A., Rivière, J. G., Tandjaoui-Lambiotte, Y., Chaïbi, K., Shahrooei, M., Darazam, I. A., Olyaei, N. A., Mansouri, D., Hatipoğlu, N., Palabiyik, F., Ozcelik, T., Novelli, G., Novelli, A., Casari, G., Aiuti, A., Carrera, P., Bondesan, S., Barzaghi, F., Rovere-Querini, P., Tresoldi, C., Franco, J. L., Rojas, J., Reyes, L. F., Bustos, I. G., Arias, A. A., Amsterdam UMC COVID-19 Biobank, van de Beek, D., Wiersinga, W. J., de Bree, G. J., Geerlings, S. E., Goorhuis, B., Grobusch, M. P., Harris, V. C., Hermans, S. M., Hovius, J. W. R., Nellen, J., van der Poll, T., Prins, J. M., Stijnis, C. S., van der Valk, M., van Vugt, M., Hollmann, M. W., Preckel, P. D. . B. & Veelo, D. P., 19 Aug 2021, In: Science immunology. 6, 62, eabl4348.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. SARS-CoV-2 vaccination for patients with inflammatory bowel disease

    Garrido, H. M. G., Grobusch, M. P., D'Haens, G. R. A. M. & Goorhuis, A., 1 Jul 2021, In: lancet. Gastroenterology & hepatology. 6, 7, p. 523 1 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 57282